Dr Reddyâs says focusing on resolving regulatory issues, cost optimisation
âLooking ahead, our priority will be to resolve pending regulatory issues, and continue to work on execution and cost structures that will enable affordable medicines for more patients,â GV Prasad, Co-chairman and CEO of Dr Reddyâs said.from Moneycontrol Business News https://www.moneycontrol.com/news/business/dr-reddyâs-says-focusingresolving-regulatory-issues-cost-optimisation_11600401.html
No comments: